SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-015101
Filing Date
2018-03-16
Accepted
2018-03-16 08:01:16
Documents
65
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv487632_10k.htm 10-K 908967
2 EXHIBIT 10.16.1 tv487632ex10-16_1.htm EX-10.16.1 32923
3 EXHIBIT 10.21.1 tv487632ex10-21_1.htm EX-10.21.1 11089
4 EXHIBIT 23.1 tv487632_ex23-1.htm EX-23.1 3163
5 EXHIBIT 23.2 tv487632_ex23-2.htm EX-23.2 3406
6 EXHIBIT 31.1 tv487632_ex31-1.htm EX-31.1 8471
7 EXHIBIT 31.2 tv487632_ex31-2.htm EX-31.2 8350
8 EXHIBIT 32.1 tv487632_ex32-1.htm EX-32.1 4218
9 EXHIBIT 32.2 tv487632_ex32-2.htm EX-32.2 4300
10 GRAPHIC tv487632_img1.jpg GRAPHIC 46046
17 GRAPHIC image_001.jpg GRAPHIC 3707
  Complete submission text file 0001144204-18-015101.txt   4465590

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT ck0001651407-20171231.xml EX-101.INS 809920
12 XBRL TAXONOMY EXTENSION SCHEMA ck0001651407-20171231.xsd EX-101.SCH 42362
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001651407-20171231_cal.xml EX-101.CAL 31740
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001651407-20171231_def.xml EX-101.DEF 260515
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001651407-20171231_lab.xml EX-101.LAB 288881
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001651407-20171231_pre.xml EX-101.PRE 303529
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 18694228
SIC: 2834 Pharmaceutical Preparations